Mark Izraelson

1.0k citations
14 papers · 548 indexed · h-index 10

Impact in

  • Immunology top 10%
    • T-cell and B-cell Immunology
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses

Papers in

    • T-cell and B-cell Immunology 10
    • Immune Cell Function and Interaction 8
    • Immunotherapy and Immune Responses 3

Mark Izraelson

14 papers receiving 546 citations

Peers

Mark Izraelson
Comparison fields: 5 of 77
  • Immunology 363
  • Microbiology 25
  • Oncology 82
  • Radiology, Nuclear Medicine and Imaging 62
  • Infectious Diseases 49
Replace Courtney J. Fleenor with:
Courtney J. Fleenor United States
Nina Chevalier Germany
Jayendra Kumar Krishnaswamy United States
Troels R. Kjær Denmark
Françoise Tielemans Belgium
Marco Künzli United States
Jennifer F. A. Swisher United States
Orit Berhani Israel
Malgorzata Krych‐Goldberg United States
Elina Shrestha United States
Mark Izraelson relative to Courtney J. Fleenor United States Courtney J. Fleenor's profile →
Citations per field
00.5×3.0×
Courtney J. Fleenor · 1×
Citations per year

Countries citing papers authored by Mark Izraelson

Since Specialization
Citations

This map shows the geographic impact of Mark Izraelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Izraelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Izraelson more than expected).

Fields of papers citing papers by Mark Izraelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Izraelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Izraelson. The network helps show where Mark Izraelson may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Izraelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Izraelson Line = papers co-authored together Mark Izraelson links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 2016116
2 2019107
3 2016102
4 201880
5 201735
6 201330
7 201627
8 202017
9 202013
10 202012
11 20215
12 20242
13 20231
14 20181

About Mark Izraelson

Mark Izraelson is a scholar working on Immunology, Microbiology, Neurology, Molecular Biology and Oncology, having authored 14 papers that have together received 548 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (3 papers), Single-cell and spatial transcriptomics (2 papers), CAR-T cell therapy research (2 papers), vaccines and immunoinformatics approaches (2 papers), Cytomegalovirus and herpesvirus research (1 paper) and Neuroinflammation and Neurodegeneration Mechanisms (1 paper). The work is most often cited by research in Immunology (363 citations), Microbiology (25 citations), Oncology (82 citations), Radiology, Nuclear Medicine and Imaging (62 citations) and Infectious Diseases (49 citations). Mark Izraelson has collaborated with scholars based in Russia, Czechia and United Kingdom. Frequent co-authors include Dmitriy M. Chudakov, Olga V. Britanova, Mikhail Shugay, Dmitriy B. Staroverov, Ilgar Z. Mamedov, Sofya A. Kasatskaya, Evgeny S. Egorov, Dmitriy A. Bolotin, Maria A. Turchaninova and Ekaterina M. Merzlyak. Their work appears in journals such as BMC Genomics, iScience, The Journal of Immunology, Immunology and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026